Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00265525
Other study ID # HBR 4855
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date November 2004
Est. completion date August 2007

Study information

Verified date March 2022
Source Ottawa Heart Institute Research Corporation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A randomized control trial (RCT) is planned to evaluate a web-based intervention (CardioFit) against usual care in increasing physical activity levels in patients with Coronary Artery Disease (CAD). We hypothesize that compared to usual care, participants in CardioFit will; a) have increased physical activity levels, b) will have a higher health-related quality of life at measurement dates and, c) will have greater improvements in psychosocial predictors.


Description:

Most existing cardiac rehabilitation programs have little ability to expand participation using traditional delivery models that emphasize supervised, facility-based programs. Futhermore, facility based programs to promote physical activity behavior in patients with coronary artery disease (CAD) are limited in their impact because most patients are unwilling to travel more than 30-40 minutes to participate in a program. CardioFit is an off-site, 26 week web-based physical activity coaching service for people with heart disease. Within the CardioFit program, patients will be assigned to an on-line "coach" and receive customized exercise programs based on their medical history, personal goals and preferences. A randomized control trial (RCT) is planned to evaluate the effectiveness of the web-based intervention at increasing physical activity levels against usual care in patients with CAD. This study is in the third phase of a three-phase research program to examine interventions to promote physical activity for the secondary prevention of Cardiovascular disease.


Recruitment information / eligibility

Status Completed
Enrollment 223
Est. completion date August 2007
Est. primary completion date June 2007
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria: - Age 20 to 80 years - English Proficiency - Internet Access (home or work) - Documented CAD (most recent cardiac diagnosis); documented Myocardial Infarction (MI), successful PCI procedure Exclusion Criteria: - Patient intends to enroll in structured cardiac rehabilitation - Hospitalization for Coronary Artery Bypass (CABG) - Hospitalization for diagnostic procedure not associated with previously documented MI - Patient coming back to hospital for planned staged PCI within 6 months - Cardiac transplantation - Presence of, or hospitalization for defibrillator implant - Hospitalization for pacemaker implantation - Unresolved unstable angina &/or hospitalization for angina (without MI or PCI) - Uncontrolled arrhythmias causing symptoms or hemodynamic compromise - Neuromuscular, musculoskeletal or rheumatoid disorders that are exacerbated by exercise - Other uncontrolled metabolic conditions (e.g. diabetes) - Chronic infectious diseases such as mononucleosis, hepatitis, AIDS - Acute systematic illness or fever - Uncontrolled tachycardia (<120 bpm) - Uncompensated congestive heart failure (&/or NYHA Class III, or IV) - 3rd degree AV block without pacemaker - Active pericarditis or myocarditis - Recent embolism - Suspected or known AAA aneurysm > 4cm - Uncontrolled hypertension (SBP > 200; DBP > 110) - Pregnancy

Study Design


Intervention

Behavioral:
CardioFit
CardioFit is a 26-week tailored web-based physical activity coaching service for individuals with Coronary Artery Disease (CAD). It has been designed to help patients develop personalized exercise programs based on their medical history, personal goals and preferences. Access to Cardio-fit is through a secured website. The cardio-fit website contains physical activity advice and heart health educational information. Each patient is assigned an on-line coach, whose role is to assist in creating safe an effective physical activity program, and to answer any questions that patients may have throughout the program.

Locations

Country Name City State
Canada London Health Sciences Centre London Ontario
Canada Unversity of Ottawa Heart Institute Ottawa Ontario

Sponsors (2)

Lead Sponsor Collaborator
Ottawa Heart Institute Research Corporation Heart and Stroke Foundation of Ontario

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Physical activity: measured at baseline (day of hospital discharge), 6 months and 12 months via: Baseline, 6 and 12 months
Secondary Measured at baseline, 6 months, and 12 months via follow-up questionnaire: Baseline, 6 and 12 months
Secondary Recurrent cardiac events Baseline, 6 and 12 months
Secondary Barriers Baseline, 6 and 12 months
Secondary Task Self-efficacy Baseline, 6 and 12 months
Secondary Outcome expectations Baseline, 6 and 12 months
Secondary Social Support Baseline, 6 and 12 months
Secondary Perceived environment Baseline, 6 and 12 months
Secondary Heart disease specific quality of life Baseline, 6 and 12 months
Secondary Use of secondary prevention medications 6 and 12 months
Secondary Pedometer (9days) 6 and 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05292079 - CAPTURER PMCF Study ( rEPIC04D )
Recruiting NCT05292118 - Navitian PMCF Study ( rEPIC04C )
Recruiting NCT05292014 - ANGIOLITE PMCF Study ( rEPIC04F )
Recruiting NCT05292092 - Essential Pro PMCF Study ( rEPIC04E )
Completed NCT05292105 - NC Xperience PMCF Study( rEPIC04B)
Terminated NCT01443754 - Hybrid Revascularisation by Combined Coronary Artery Bypass Graft (CABG) and PCI in Multivessel Coronary Disease N/A
Completed NCT01435031 - EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions N/A
Completed NCT00783302 - Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care N/A
Completed NCT00543400 - Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE) Phase 2
Completed NCT05516784 - Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics Profile Phase 4
Completed NCT02873052 - MyoVista Measurements in Patients With Atherosclerosis and CAD
Terminated NCT02984891 - Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging
Completed NCT05292144 - Xperience Pro PMCF Study
Completed NCT02554292 - Post Market Surveillance of SeQuent Please Neo With Scoring Balloon
Recruiting NCT06052319 - A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population
Completed NCT03570697 - Imaging of Coronary Plaques in Participants Treated With Evolocumab Phase 3
Terminated NCT05508893 - Screening for Coronary Artery Disease USing Primary Evaluation With Coronary CTA in Aviation Medicine (SUSPECT) N/A
Completed NCT02341664 - Patient and Provider Assessment of Lipid Management Registry
Completed NCT02098772 - Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol Phase 3
Recruiting NCT05617599 - SUPRAFLEX CRUZ PMCF Study ( rEpic05 )